At the heart of Akttyva Therapeutics’ innovation is their proprietary AI−assisted platform, AIDE−360

At the heart of Akttyva Therapeutics’ innovation is their proprietary AI−assisted platform, AIDE−360. This advanced technology integrates machine learning algorithms with vast biomedical data to streamline and enhance the drug discovery process. AIDE−360 is designed to analyze complex biological data sets, predict potential drug candidates, and optimize the development process, significantly reducing the time and cost associated with bringing new therapies to patients. AIDE−360 has garnered significant recognition for its innovative approach, winning numerous prestigious awards. Among these accolades are honors from the National Science Foundation, IBM, and MassChallenge, high− lighting the platform’s potential to transform the drug discovery landscape. These awards not only validate the efficacy of AIDE−360 but also underscore Akttyva Therapeutics’ role as a leader in the integration of AI into pharmaceutical research.